Outpace Bio

Seattle, United States

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

$144.0M raised

Aug 2024

Series B

Top Investors

Qiming Venture PartnersRA Capital ManagementPlayground GlobalLyell ImmunopharmaArtis Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Outpace Bio raised?

Outpace Bio has raised $144.0M in total funding. The most recent round was Series B. The last funding was announced in August 2024.

Who are Outpace Bio's investors?

Outpace Bio's investors include Qiming Venture Partners, RA Capital Management, Playground Global, Lyell Immunopharma, Artis Ventures.

Where is Outpace Bio headquartered?

Outpace Bio is headquartered in Seattle, United States.

What does Outpace Bio do?

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

What stage is Outpace Bio at?

Outpace Bio is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 1, 2024.

MLA

"Outpace Bio — Funding & Investors." VCBacked, August 1, 2024, https://www.vcbacked.co/company/outpace-bio. Accessed June 3, 2026.

APA

VCBacked. (2024). Outpace Bio — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/outpace-bio

Wikipedia (cite web)

{{cite web |title=Outpace Bio — Funding & Investors |url=https://www.vcbacked.co/company/outpace-bio |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 1, 2024.